http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-162319-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5cd84f92e5e2ff95dfd19e4e329db3b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-284
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2813
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-36
filingDate 2006-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f30bdeb202322e20adfac66162e4eb6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d2d71217b99f2dc633579a236196730
publicationDate 2017-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MY-162319-A
titleOfInvention Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
abstract THE PRESENT INVENTION PERTAINS TO A PHARMACEUTICAL COMPOSITION COMPRISING TILE COMPOUND OF THE FORMULA (I) IN A HIGH CONCENTRATION AND AT LEAST ONE PHARMACEUTICALLY ACCEPTABLE EXCIPIENT, THE USE OF THE COMPOSITION FOR THE TREATMENT OF HYPER-PROLIFERATIVE DISEASES, SUCH AS CANCER, EITHER AS A SOLE AGENT, OR IN COMBINATION WITH OTHER ANTI-CANCER THERAPIES, AND THE PROCESS FOR PREPARING OF SAID COMPOSITION.
priorityDate 2005-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477993

Total number of triples: 30.